IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:IVG • NL0015000LU4

18.95 EUR
0 (0%)
Last: Feb 4, 2026, 02:12 PM
Fundamental Rating

4

IVG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 112 industry peers in the Machinery industry. While IVG is still in line with the averages on profitability rating, there are concerns on its financial health. IVG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • IVG had positive earnings in the past year.
  • In the past year IVG had a positive cash flow from operations.
  • Of the past 5 years IVG 4 years were profitable.
  • IVG had a positive operating cash flow in each of the past 5 years.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.73%, IVG is doing worse than 61.61% of the companies in the same industry.
  • The Return On Equity of IVG (12.39%) is better than 74.11% of its industry peers.
  • IVG has a Return On Invested Capital (4.53%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.91%.
  • The last Return On Invested Capital (4.53%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROIC 4.53%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.17%, IVG is doing worse than 62.50% of the companies in the same industry.
  • IVG's Profit Margin has improved in the last couple of years.
  • IVG's Operating Margin of 5.00% is on the low side compared to the rest of the industry. IVG is outperformed by 60.71% of its industry peers.
  • IVG's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 16.49%, IVG is doing worse than 90.18% of the companies in the same industry.
  • In the last couple of years the Gross Margin of IVG has grown nicely.
Industry RankSector Rank
OM 5%
PM (TTM) 2.17%
GM 16.49%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

  • IVG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, IVG has less shares outstanding
  • Compared to 5 years ago, IVG has more shares outstanding
  • The debt/assets ratio for IVG has been reduced compared to a year ago.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • IVG has an Altman-Z score of 1.77. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
  • IVG has a Altman-Z score (1.77) which is comparable to the rest of the industry.
  • IVG has a debt to FCF ratio of 14.82. This is a negative value and a sign of low solvency as IVG would need 14.82 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 14.82, IVG is doing worse than 66.96% of the companies in the same industry.
  • A Debt/Equity ratio of 1.35 is on the high side and indicates that IVG has dependencies on debt financing.
  • The Debt to Equity ratio of IVG (1.35) is worse than 83.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Altman-Z 1.77
ROIC/WACC0.6
WACC7.5%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of IVG (1.98) is better than 71.43% of its industry peers.
  • A Quick Ratio of 1.40 indicates that IVG should not have too much problems paying its short term obligations.
  • IVG's Quick ratio of 1.40 is fine compared to the rest of the industry. IVG outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.4
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

4

3. Growth

3.1 Past

  • IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.43%.
  • Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.82% on average per year.
  • IVG shows a decrease in Revenue. In the last year, the revenue decreased by -7.24%.
  • IVG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.06% yearly.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.81% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.30% on average over the next years.
EPS Next Y-25.28%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.14, IVG is valued correctly.
  • 85.71% of the companies in the same industry are more expensive than IVG, based on the Price/Earnings ratio.
  • IVG is valuated rather cheaply when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
  • IVG is valuated reasonably with a Price/Forward Earnings ratio of 8.91.
  • IVG's Price/Forward Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 91.07% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of IVG to the average of the S&P500 Index (25.51), we can say IVG is valued rather cheaply.
Industry RankSector Rank
PE 14.14
Fwd PE 8.91
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IVG is valued cheaper than 81.25% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.85
EV/EBITDA 5.6
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.11%
EPS Next 3Y8.02%

More info and screens

4

5. Dividend

5.1 Amount

  • IVG has a Yearly Dividend Yield of 1.75%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.53, IVG pays a bit more dividend than its industry peers.
  • IVG's Dividend Yield is comparable with the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • IVG pays out 27.33% of its income as dividend. This is a sustainable payout ratio.
DP27.33%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

IVECO GROUP NV

BIT:IVG (2/4/2026, 2:12:30 PM)

18.95

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06
Earnings (Next)02-12
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.14B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts70.77
Price Target20.11 (6.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-3.77%
EPS NY rev (3m)-17.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.12%
Valuation
Industry RankSector Rank
PE 14.14
Fwd PE 8.91
P/S 0.35
P/FCF 12.85
P/OCF 3.99
P/B 1.98
P/tB 9.31
EV/EBITDA 5.6
EPS(TTM)1.34
EY7.07%
EPS(NY)2.13
Fwd EY11.22%
FCF(TTM)1.47
FCFY7.78%
OCF(TTM)4.75
OCFY25.08%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROCE 6%
ROIC 4.53%
ROICexc 5.79%
ROICexgc 7.34%
OM 5%
PM (TTM) 2.17%
GM 16.49%
FCFM 2.7%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Debt/EBITDA 2.37
Cap/Depr 119.97%
Cap/Sales 6%
Interest Coverage 250
Cash Conversion 86.98%
Profit Quality 124.22%
Current Ratio 1.98
Quick Ratio 1.4
Altman-Z 1.77
F-Score6
WACC7.5%
ROIC/WACC0.6
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-25.28%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


What is the valuation status for IVG stock?

ChartMill assigns a valuation rating of 6 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for IVECO GROUP NV?

IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.


How financially healthy is IVECO GROUP NV?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


Can you provide the expected EPS growth for IVG stock?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -25.28% in the next year.